Biotechnology
The Biotechnology industry has a total of 598 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.34 billion.
Market Cap
1.14T
Revenue
110.34B
Profits
-41.83B
PE Ratio
n/a
Profit Margin
-37.91%
Dividend Yield
0.04%
598 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 123.47B | -2.17% | 1,032,940 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 81.15B | 1.17% | 792,516 | 14.34B |
| 3 | ARGX | argenx SE | 46.42B | -1.32% | 224,866 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.11B | -2.36% | 1,299,358 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.89B | -0.78% | 321,760 | 5.34B |
| 6 | INSM | Insmed Incorporated | 31.54B | -2.02% | 2,302,305 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 27.38B | 2.73% | 4,403,188 | 2.38B |
| 8 | BNTX | BioNTech SE | 26.97B | -2.49% | 592,797 | 3.70B |
| 9 | MRNA | Moderna, Inc. | 20.87B | -1.35% | 9,376,987 | 1.94B |
| 10 | RVMD | Revolution Medicines, Inc. | 20.14B | -0.39% | 2,464,051 | - |
| 11 | ROIV | Roivant Sciences Ltd. | 20.11B | -2.90% | 3,884,333 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.91B | -1.21% | 1,671,751 | 5.14B |
| 13 | GMAB | Genmab A/S | 18.00B | 0.71% | 1,924,764 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.86B | 3.68% | 1,413,082 | 845.52M |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 13.54B | 1.00% | 3,039,836 | 943.71M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 12.70B | -1.47% | 2,032,586 | 502.08M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.55B | -2.41% | 1,866,186 | - |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.72B | 0.23% | 724,583 | 4.27B |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 11.49B | -3.22% | 1,953,089 | 3.22B |
| 20 | RNAM | Avidity Biosciences, Inc. | 11.30B | 0.05% | 1 | 18.76M |
| 21 | IBRX | ImmunityBio, Inc. | 10.73B | 6.75% | 40,697,419 | 113.29M |
| 22 | EXEL | Exelixis, Inc. | 10.66B | -6.88% | 7,145,488 | 2.32B |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.02B | 1.06% | 217,650 | 958.40M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.21B | -1.83% | 424,832 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.05B | -6.74% | 1,233,270 | 6.23M |
| 26 | TECH | Bio-Techne Corporation | 9.05B | -2.00% | 1,538,506 | 1.22B |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.01B | 1.68% | 1,983,766 | 1.09B |
| 28 | PCVX | Vaxcyte, Inc. | 8.92B | 0.39% | 1,291,655 | - |
| 29 | AXSM | Axsome Therapeutics, Inc. | 8.51B | 1.52% | 566,739 | 638.50M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.24B | 0.46% | 2,062,688 | 1.40B |
| 31 | NUVL | Nuvalent, Inc. | 7.96B | -0.65% | 395,732 | - |
| 32 | CYTK | Cytokinetics, Incorporated | 7.57B | -1.27% | 1,143,855 | 88.04M |
| 33 | KRYS | Krystal Biotech, Inc. | 7.57B | -6.11% | 318,074 | 389.13M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 7.36B | -1.37% | 882,096 | 39.21M |
| 35 | ACLX | Arcellx, Inc. | 6.67B | 0.20% | 1,388,732 | 22.29M |
| 36 | BLTE | Belite Bio, Inc | 6.66B | -6.68% | 406,602 | - |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.48B | 2.38% | 959,070 | 189.76M |
| 38 | COGT | Cogent Biosciences, Inc. | 6.26B | 0.10% | 1,196,688 | - |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 6.01B | 2.35% | 942,700 | 46.02M |
| 40 | CAI | Caris Life Sciences, Inc. | 5.84B | 2.58% | 3,128,200 | 812.03M |
| 41 | CRSP | CRISPR Therapeutics AG | 5.83B | 1.05% | 1,329,594 | 3.51M |
| 42 | IMVT | Immunovant, Inc. | 5.65B | 0.07% | 1,065,614 | - |
| 43 | PTCT | PTC Therapeutics, Inc. | 5.49B | -2.67% | 1,949,380 | 1.73B |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.44B | -2.38% | 447,945 | 521.31M |
| 45 | CELC | Celcuity Inc. | 5.01B | -3.05% | 492,381 | - |
| 46 | CGON | CG Oncology, Inc. | 4.88B | -1.77% | 616,407 | 4.04M |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.79B | 1.31% | 877,821 | - |
| 48 | TERN | Terns Pharmaceuticals, Inc. | 4.57B | -0.21% | 1,611,265 | - |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.51B | -0.07% | 3,638,093 | 634.21M |
| 50 | ERAS | Erasca, Inc. | 4.50B | 6.37% | 3,607,199 | - |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.44B | -1.78% | 1,409,170 | - |
| 52 | GPCR | Structure Therapeutics Inc. | 4.35B | -0.13% | 507,144 | - |
| 53 | TGTX | TG Therapeutics, Inc. | 4.30B | -2.29% | 1,109,524 | 616.29M |
| 54 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.26B | -1.02% | 1,125,582 | 7.70M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.04B | 2.14% | 153,935 | 268.09M |
| 56 | ADMA | ADMA Biologics, Inc. | 3.95B | 6.49% | 5,771,104 | 510.17M |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 3.89B | -7.13% | 2,993,927 | 1.07B |
| 58 | CNTA | Centessa Pharmaceuticals plc | 3.87B | -1.30% | 958,397 | 15.00M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.85B | -1.48% | 2,005,788 | - |
| 60 | CORT | Corcept Therapeutics Incorporated | 3.83B | 0.76% | 1,127,626 | 761.41M |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.77B | -7.42% | 1,963,126 | 22.50M |
| 62 | ALMS | Alumis Inc. | 3.70B | 0.10% | 874,566 | 22.12M |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.54B | -1.57% | 1,174,469 | 7.50M |
| 64 | LEGN | Legend Biotech Corporation | 3.41B | -2.92% | 1,786,579 | 909.05M |
| 65 | SYRE | Spyre Therapeutics, Inc. | 3.34B | -1.21% | 649,167 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.33B | -0.85% | 1,363,511 | - |
| 67 | TARS | Tarsus Pharmaceuticals, Inc. | 3.30B | 2.53% | 393,399 | 451.36M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.19B | -2.43% | 669,815 | - |
| 69 | VRDN | Viridian Therapeutics, Inc. | 3.09B | 2.96% | 1,049,065 | 70.85M |
| 70 | ARQT | Arcutis Biotherapeutics, Inc. | 3.07B | -8.19% | 1,977,274 | 376.07M |
| 71 | RCUS | Arcus Biosciences, Inc. | 3.00B | 17.53% | 3,229,921 | 247.00M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.92B | 3.47% | 2,629,580 | 588.99M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.90B | 2.61% | 662,403 | 218.71M |
| 74 | VERA | Vera Therapeutics, Inc. | 2.88B | -0.91% | 879,157 | - |
| 75 | BEAM | Beam Therapeutics Inc. | 2.85B | 0.81% | 2,998,211 | 139.74M |
| 76 | TVTX | Travere Therapeutics, Inc. | 2.72B | -0.87% | 1,501,231 | 490.73M |
| 77 | LQDA | Liquidia Corporation | 2.69B | -0.26% | 1,283,767 | 69.22M |
| 78 | DYN | Dyne Therapeutics, Inc. | 2.66B | 3.39% | 1,902,270 | - |
| 79 | APLS | Apellis Pharmaceuticals, Inc. | 2.65B | -1.24% | 1,306,276 | 1.00B |
| 80 | WVE | Wave Life Sciences Ltd. | 2.61B | -0.57% | 2,014,688 | 42.73M |
| 81 | IRON | Disc Medicine, Inc. | 2.54B | -0.12% | 379,941 | - |
| 82 | ADPT | Adaptive Biotechnologies Corporation | 2.48B | 0.62% | 1,634,549 | 276.98M |
| 83 | IMNM | Immunome, Inc. | 2.45B | 1.60% | 1,362,516 | 9.68M |
| 84 | OCUL | Ocular Therapeutix, Inc. | 2.39B | 22.82% | 17,202,081 | 51.95M |
| 85 | DNTH | Dianthus Therapeutics, Inc. | 2.39B | 0.04% | 612,500 | 3.08M |
| 86 | TLX | Telix Pharmaceuticals Limited | 2.34B | -2.76% | 354,157 | 803.79M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.32B | 0.21% | 766,125 | - |
| 88 | GLPG | Galapagos NV | 2.23B | 1.28% | 68,807 | 1.31B |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.22B | -1.58% | 1,647,151 | 673.00M |
| 90 | MAZE | Maze Therapeutics, Inc. | 2.19B | 0.04% | 201,375 | 2.50M |
| 91 | AAPG | Ascentage Pharma Group International | 2.12B | -3.53% | 2,788 | 54.52M |
| 92 | STOK | Stoke Therapeutics, Inc. | 2.10B | 0.77% | 898,402 | 205.63M |
| 93 | ZLAB | Zai Lab Limited | 2.06B | -4.16% | 890,725 | 460.16M |
| 94 | SLNO | Soleno Therapeutics, Inc. | 2.02B | -0.03% | 1,875,197 | 190.41M |
| 95 | NUVB | Nuvation Bio Inc. | 2.00B | -1.18% | 6,102,901 | 26.75M |
| 96 | CLDX | Celldex Therapeutics, Inc. | 2.00B | -0.30% | 751,413 | 1.55M |
| 97 | SNDX | Syndax Pharmaceuticals, Inc. | 1.95B | 1.98% | 1,675,676 | 172.35M |
| 98 | RXRX | Recursion Pharmaceuticals, Inc. | 1.92B | -1.09% | 13,887,781 | 74.68M |
| 99 | NKTR | Nektar Therapeutics | 1.91B | -0.90% | 881,257 | 62.60M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.89B | 0.28% | 1,159,161 | 283.06M |
| 101 | OLMA | Olema Pharmaceuticals, Inc. | 1.89B | -0.74% | 846,930 | - |
| 102 | MESO | Mesoblast Limited | 1.89B | -8.45% | 592,124 | 65.38M |
| 103 | NTLA | Intellia Therapeutics, Inc. | 1.82B | 12.05% | 14,426,155 | 67.67M |
| 104 | PHVS | Pharvaris N.V. | 1.82B | -1.37% | 143,151 | - |
| 105 | GLTO | Galecto, Inc. | 1.81B | 0.34% | 182,751 | - |
| 106 | VCEL | Vericel Corporation | 1.79B | -0.90% | 531,519 | 276.26M |
| 107 | RAPT | RAPT Therapeutics, Inc. | 1.79B | 0.07% | 10,462,604 | - |
| 108 | PVLA | Palvella Therapeutics, Inc. | 1.78B | -1.78% | 327,922 | - |
| 109 | ELVN | Enliven Therapeutics, Inc. | 1.75B | -0.64% | 559,365 | - |
| 110 | RLAY | Relay Therapeutics, Inc. | 1.75B | -4.58% | 2,839,009 | 15.36M |
| 111 | ZYME | Zymeworks Inc. | 1.74B | 0.09% | 703,029 | 105.97M |
| 112 | MANE | Veradermics, Incorporated | 1.74B | 1.68% | 221,320 | - |
| 113 | TYRA | Tyra Biosciences, Inc. | 1.74B | -2.37% | 680,031 | - |
| 114 | DFTX | Definium Therapeutics, Inc. | 1.71B | -1.55% | 2,566,392 | - |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | -3.41% | 1,174,028 | 54.03M |
| 116 | SRPT | Sarepta Therapeutics, Inc. | 1.71B | -2.63% | 2,507,413 | 2.20B |
| 117 | KOD | Kodiak Sciences Inc. | 1.70B | 2.09% | 458,096 | - |
| 118 | INVA | Innoviva, Inc. | 1.69B | -0.57% | 718,077 | 411.33M |
| 119 | HRMY | Harmony Biosciences Holdings, Inc. | 1.67B | 1.26% | 992,795 | 868.45M |
| 120 | IMCR | Immunocore Holdings plc | 1.66B | 1.15% | 266,513 | 400.02M |
| 121 | OCS | Oculis Holding AG | 1.65B | -2.72% | 439,818 | 992.00K |
| 122 | NVAX | Novavax, Inc. | 1.65B | -0.30% | 3,769,951 | 1.12B |
| 123 | ORKA | Oruka Therapeutics, Inc. | 1.63B | -2.09% | 297,594 | - |
| 124 | NRIX | Nurix Therapeutics, Inc. | 1.63B | -1.00% | 523,104 | 83.98M |
| 125 | TRVI | Trevi Therapeutics, Inc. | 1.61B | 5.45% | 1,451,479 | - |
| 126 | ARDX | Ardelyx, Inc. | 1.59B | -1.22% | 2,499,598 | 407.32M |
| 127 | BHVN | Biohaven Ltd. | 1.57B | 2.52% | 1,620,528 | - |
| 128 | IOVA | Iovance Biotherapeutics, Inc. | 1.56B | -1.81% | 12,147,549 | 263.50M |
| 129 | MBX | MBX Biosciences, Inc. | 1.55B | 1.29% | 539,663 | - |
| 130 | TNGX | Tango Therapeutics, Inc. | 1.55B | 3.50% | 1,912,593 | 66.50M |
| 131 | GENB | Generate Biomedicines, Inc. | 1.55B | -3.79% | 1,457,776 | 31.89M |
| 132 | NBTX | Nanobiotix S.A. | 1.53B | 2.96% | 71,404 | 11.93M |
| 133 | ANAB | AnaptysBio, Inc. | 1.52B | -0.25% | 358,546 | 169.47M |
| 134 | EYPT | EyePoint, Inc. | 1.52B | 4.44% | 1,634,695 | 42.34M |
| 135 | SION | Sionna Therapeutics, Inc. | 1.51B | -7.17% | 235,398 | - |
| 136 | CRVS | Corvus Pharmaceuticals, Inc. | 1.50B | -2.03% | 577,603 | - |
| 137 | SVRA | Savara Inc. | 1.49B | -0.17% | 1,051,590 | - |
| 138 | VIR | Vir Biotechnology, Inc. | 1.47B | 2.75% | 10,545,152 | 68.56M |
| 139 | GLUE | Monte Rosa Therapeutics, Inc. | 1.47B | 4.23% | 1,169,564 | 181.54M |
| 140 | ORIC | ORIC Pharmaceuticals, Inc. | 1.39B | 3.20% | 1,018,868 | - |
| 141 | CAPR | Capricor Therapeutics, Inc. | 1.39B | -3.83% | 669,330 | 11.13M |
| 142 | ZBIO | Zenas BioPharma, Inc. | 1.37B | -3.00% | 398,023 | 15.00M |
| 143 | RAPP | Rapport Therapeutics, Inc. | 1.35B | -2.27% | 244,560 | - |
| 144 | IMTX | Immatics N.V. | 1.34B | -3.38% | 520,390 | 99.45M |
| 145 | ATAI | AtaiBeckley Inc. | 1.34B | 1.38% | 3,980,267 | 3.02M |
| 146 | DBVT | DBV Technologies S.A. | 1.31B | 10.77% | 311,557 | 5.50M |
| 147 | SEPN | Septerna, Inc. | 1.28B | -1.31% | 514,479 | 22.05M |
| 148 | PGEN | Precigen, Inc. | 1.28B | -4.49% | 7,928,378 | 6.31M |
| 149 | MLTX | MoonLake Immunotherapeutics | 1.27B | 0.97% | 940,936 | - |
| 150 | TSHA | Taysha Gene Therapies, Inc. | 1.24B | - | 2,548,095 | 6.31M |
| 151 | IVA | Inventiva S.A. | 1.18B | -3.08% | 164,235 | 19.93M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.16B | 5.82% | 4,921,687 | 75.13M |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.13B | 4.53% | 223,190 | 1.40M |
| 154 | BCAX | Bicara Therapeutics Inc. | 1.11B | 4.83% | 346,290 | - |
| 155 | SANA | Sana Biotechnology, Inc. | 1.11B | -1.43% | 1,933,037 | - |
| 156 | PHAR | Pharming Group N.V. | 1.10B | -1.90% | 27,339 | 362.27M |
| 157 | DAWN | Day One Biopharmaceuticals, Inc. | 1.07B | -2.17% | 1,419,790 | 158.18M |
| 158 | AKTS | Aktis Oncology, Inc. | 1.05B | -0.65% | 133,676 | 5.56M |
| 159 | CMPX | Compass Therapeutics, Inc. | 1.01B | 0.53% | 2,236,438 | 850.00K |
| 160 | VTYX | Ventyx Biosciences, Inc. | 1.00B | 0.07% | 1,784,478 | - |
| 161 | XERS | Xeris Biopharma Holdings, Inc. | 998.86M | -1.63% | 5,043,049 | 291.85M |
| 162 | GHRS | GH Research PLC | 993.09M | 7.81% | 292,075 | - |
| 163 | GERN | Geron Corporation | 989.45M | -7.74% | 14,162,008 | 183.88M |
| 164 | FTRE | Fortrea Holdings Inc. | 987.36M | -1.49% | 1,666,176 | 2.72B |
| 165 | VALN | Valneva SE | 971.11M | -1.53% | 11,485 | 211.09M |
| 166 | TBPH | Theravance Biopharma, Inc. | 960.24M | 3.84% | 621,507 | 80.33M |
| 167 | AVBP | ArriVent BioPharma, Inc. | 956.90M | 0.91% | 864,454 | - |
| 168 | CGEM | Cullinan Therapeutics, Inc. | 944.63M | 3.16% | 999,565 | - |
| 169 | MNKD | MannKind Corporation | 935.08M | -7.47% | 9,572,390 | 348.97M |
| 170 | MRVI | Maravai LifeSciences Holdings, Inc. | 928.01M | 1.40% | 1,100,798 | 185.74M |
| 171 | SPRY | ARS Pharmaceuticals, Inc. | 906.44M | -1.19% | 789,319 | 142.77M |
| 172 | CTMX | CytomX Therapeutics, Inc. | 904.79M | -0.56% | 1,601,645 | 113.63M |
| 173 | PHAT | Phathom Pharmaceuticals, Inc. | 903.03M | -8.76% | 1,950,150 | 175.11M |
| 174 | XNCR | Xencor, Inc. | 900.60M | -3.84% | 678,938 | 125.58M |
| 175 | ABUS | Arbutus Biopharma Corporation | 898.15M | 0.21% | 1,356,579 | 14.61M |
| 176 | SGP | SpyGlass Pharma, Inc. | 890.57M | -4.54% | 57,862 | - |
| 177 | URGN | UroGen Pharma Ltd. | 890.31M | -12.35% | 2,681,407 | 109.79M |
| 178 | SLS | SELLAS Life Sciences Group, Inc. | 859.92M | 2.43% | 7,553,582 | - |
| 179 | ARVN | Arvinas, Inc. | 856.44M | 0.90% | 675,978 | 262.60M |
| 180 | OMER | Omeros Corporation | 849.39M | -0.58% | 769,223 | - |
| 181 | PRME | Prime Medicine, Inc. | 825.00M | 0.87% | 3,115,740 | 5.98M |
| 182 | ANNX | Annexon, Inc. | 822.79M | -1.43% | 3,051,403 | - |
| 183 | JANX | Janux Therapeutics, Inc. | 816.36M | -1.40% | 762,301 | 10.00M |
| 184 | KALV | KalVista Pharmaceuticals, Inc. | 811.77M | -1.35% | 630,900 | 1.43M |
| 185 | EVMN | Evommune, Inc. | 807.33M | -1.50% | 167,451 | 13.00M |
| 186 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 803.89M | 0.20% | 174,016 | - |
| 187 | EIKN | Eikon Therapeutics, Inc. | 803.29M | 7.98% | 420,433 | - |
| 188 | DRUG | Bright Minds Biosciences Inc. | 796.87M | -1.20% | 75,859 | - |
| 189 | GYRE | Gyre Therapeutics, Inc. | 796.20M | 6.31% | 175,330 | 107.27M |
| 190 | AGMB | AgomAb Therapeutics NV | 790.02M | 1.19% | 59,182 | - |
| 191 | MPLT | MapLight Therapeutics, Inc. | 768.09M | 1.91% | 101,200 | - |
| 192 | KURA | Kura Oncology, Inc. | 755.31M | -0.57% | 971,866 | 104.03M |
| 193 | MDXG | MiMedx Group, Inc. | 725.00M | -0.20% | 718,532 | 418.63M |
| 194 | PROK | ProKidney Corp. | 694.93M | 3.12% | 611,131 | 744.00K |
| 195 | ENGN | enGene Holdings Inc. | 669.89M | -1.09% | 94,137 | - |
| 196 | LXRX | Lexicon Pharmaceuticals, Inc. | 666.25M | 6.12% | 2,736,441 | 70.86M |
| 197 | VOR | Vor Biopharma Inc. | 660.17M | 2.98% | 883,116 | - |
| 198 | QURE | uniQure N.V. | 654.06M | -32.82% | 16,763,730 | 16.10M |
| 199 | DRTS | Alpha Tau Medical Ltd. | 650.57M | -1.68% | 170,485 | - |
| 200 | JBIO | Jade Biosciences, Inc. | 649.58M | -4.79% | 151,478 | - |
| 201 | ZURA | Zura Bio Limited | 641.36M | 2.11% | 421,165 | - |
| 202 | ANRO | Alto Neuroscience, Inc. | 640.90M | 4.77% | 265,506 | - |
| 203 | OCGN | Ocugen, Inc. | 636.10M | 6.59% | 10,032,181 | 5.37M |
| 204 | RIGL | Rigel Pharmaceuticals, Inc. | 627.13M | -0.55% | 329,245 | 282.08M |
| 205 | MGTX | MeiraGTx Holdings plc | 610.12M | 0.26% | 317,674 | 27.42M |
| 206 | YDES | YD Bio Limited | 608.27M | 0.82% | 14,174 | 510.36K |
| 207 | LBRX | LB Pharmaceuticals Inc | 599.84M | -1.25% | 171,237 | - |
| 208 | ALLO | Allogene Therapeutics, Inc. | 595.53M | -4.68% | 3,571,231 | 22.00K |
| 209 | REPL | Replimune Group, Inc. | 591.22M | -6.41% | 1,458,334 | - |
| 210 | DSGN | Design Therapeutics, Inc. | 582.74M | -2.01% | 150,019 | - |
| 211 | CRMD | CorMedix Inc. | 568.07M | 1.12% | 1,230,764 | 214.30M |
| 212 | LRMR | Larimar Therapeutics, Inc. | 567.93M | -1.51% | 2,267,977 | - |
| 213 | CTNM | Contineum Therapeutics, Inc. | 560.36M | - | 212,717 | - |
| 214 | FBRX | Forte Biosciences, Inc. | 546.53M | 1.42% | 240,254 | - |
| 215 | NMRA | Neumora Therapeutics, Inc. | 543.80M | -8.31% | 1,964,455 | - |
| 216 | RCKT | Rocket Pharmaceuticals, Inc. | 539.59M | -0.80% | 4,695,117 | - |
| 217 | ALT | Altimmune, Inc. | 520.96M | -3.48% | 2,107,313 | 20.00K |
| 218 | LXEO | Lexeo Therapeutics, Inc. | 520.40M | -0.70% | 321,276 | - |
| 219 | FULC | Fulcrum Therapeutics, Inc. | 520.15M | -6.80% | 3,560,167 | 80.00M |
| 220 | ADCT | ADC Therapeutics SA | 517.81M | 1.95% | 468,406 | 75.21M |
| 221 | LYEL | Lyell Immunopharma, Inc. | 511.98M | 0.42% | 80,502 | 41.00K |
| 222 | ZVRA | Zevra Therapeutics, Inc. | 511.74M | 1.79% | 491,125 | 84.39M |
| 223 | PRTA | Prothena Corporation plc | 506.03M | 8.42% | 675,269 | 9.68M |
| 224 | EPRX | Eupraxia Pharmaceuticals Inc. | 498.56M | 1.34% | 188,064 | - |
| 225 | KYTX | Kyverna Therapeutics, Inc. | 486.46M | 3.71% | 643,647 | - |
| 226 | IVVD | Invivyd, Inc. | 485.02M | 1.78% | 1,523,891 | 50.04M |
| 227 | SLDB | Solid Biosciences Inc. | 483.04M | -0.16% | 535,120 | - |
| 228 | VNDA | Vanda Pharmaceuticals Inc. | 482.91M | -8.31% | 2,598,650 | 216.11M |
| 229 | FDMT | 4D Molecular Therapeutics, Inc. | 475.90M | -3.42% | 1,395,164 | 120.00K |
| 230 | LCTX | Lineage Cell Therapeutics, Inc. | 472.54M | 1.56% | 1,200,232 | 10.82M |
| 231 | TENX | Tenax Therapeutics, Inc. | 471.43M | -3.17% | 125,267 | - |
| 232 | ASMB | Assembly Biosciences, Inc. | 469.45M | -0.54% | 57,228 | 37.19M |
| 233 | RGNX | REGENXBIO Inc. | 467.76M | 2.21% | 1,419,227 | 161.32M |
| 234 | VTVT | vTv Therapeutics Inc. | 451.50M | -4.65% | 53,241 | 17.00K |
| 235 | VSTM | Verastem, Inc. | 449.20M | 1.75% | 1,104,199 | 13.38M |
| 236 | PEPG | PepGen Inc. | 448.93M | 4.98% | 442,429 | - |
| 237 | AUTL | Autolus Therapeutics plc | 444.46M | -2.34% | 1,046,421 | 51.13M |
| 238 | IMMX | Immix Biopharma, Inc. | 440.53M | 3.59% | 352,860 | - |
| 239 | TECX | Tectonic Therapeutic, Inc. | 431.86M | -1.92% | 185,018 | - |
| 240 | LENZ | LENZ Therapeutics, Inc. | 428.05M | 1.41% | 1,166,776 | 17.50M |
| 241 | KROS | Keros Therapeutics, Inc. | 423.78M | -1.97% | 317,767 | 246.72M |
| 242 | ENTA | Enanta Pharmaceuticals, Inc. | 421.07M | 1.47% | 188,166 | 66.98M |
| 243 | ABSI | Absci Corporation | 421.04M | 2.19% | 2,519,297 | 2.82M |
| 244 | TRDA | Entrada Therapeutics, Inc. | 420.48M | -2.10% | 253,396 | 25.42M |
| 245 | AVXL | Anavex Life Sciences Corp. | 419.80M | 2.26% | 922,652 | - |
| 246 | DMAC | DiaMedica Therapeutics Inc. | 416.84M | -2.14% | 196,207 | - |
| 247 | UPB | Upstream Bio, Inc. | 416.10M | 0.26% | 1,655,255 | 2.80M |
| 248 | ARMP | Armata Pharmaceuticals, Inc. | 415.77M | 6.13% | 28,911 | 5.05M |
| 249 | DNA | Ginkgo Bioworks Holdings, Inc. | 410.36M | 4.44% | 1,833,089 | 170.16M |
| 250 | IPSC | Century Therapeutics, Inc. | 406.00M | -2.59% | 519,022 | 113.34M |
| 251 | PRTC | PureTech Health plc | 401.96M | 5.72% | 9,450 | 6.39M |
| 252 | IMMP | Immutep Limited | 400.69M | -4.64% | 167,328 | 5.28M |
| 253 | NAGE | Niagen Bioscience, Inc. | 399.64M | -1.19% | 1,024,490 | 124.71M |
| 254 | BCYC | Bicycle Therapeutics plc | 397.48M | - | 236,720 | 28.34M |
| 255 | NBP | NovaBridge Biosciences | 397.18M | 5.03% | 496,237 | - |
| 256 | AURA | Aura Biosciences, Inc. | 389.91M | 4.24% | 302,282 | - |
| 257 | HELP | Cybin Inc. | 380.77M | 3.54% | 396,854 | - |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 380.48M | 4.06% | 506,196 | - |
| 259 | GLSI | Greenwich LifeSciences, Inc. | 379.48M | -1.19% | 122,339 | - |
| 260 | CADL | Candel Therapeutics, Inc. | 374.29M | -2.67% | 1,124,904 | - |
| 261 | BNTC | Benitec Biopharma Inc. | 370.98M | -0.64% | 54,647 | - |
| 262 | ACRS | Aclaris Therapeutics, Inc. | 367.82M | 6.27% | 4,744,627 | 7.83M |
| 263 | MNPR | Monopar Therapeutics Inc. | 357.38M | -2.42% | 162,671 | - |
| 264 | RLMD | Relmada Therapeutics, Inc. | 354.93M | 6.14% | 574,827 | - |
| 265 | STRO | Sutro Biopharma, Inc. | 340.37M | 1.47% | 78,962 | 105.65M |
| 266 | ALDX | Aldeyra Therapeutics, Inc. | 338.23M | 2.93% | 879,091 | - |
| 267 | CLYM | Climb Bio, Inc. | 337.55M | -1.12% | 662,433 | - |
| 268 | FHTX | Foghorn Therapeutics Inc. | 337.43M | 1.41% | 132,854 | 24.52M |
| 269 | AVTX | Avalo Therapeutics, Inc. | 332.86M | 2.74% | 482,900 | 192.00K |
| 270 | PBYI | Puma Biotechnology, Inc. | 326.63M | 12.63% | 1,053,707 | 228.37M |
| 271 | RZLT | Rezolute, Inc. | 326.16M | -2.18% | 1,959,239 | - |
| 272 | XOMA | XOMA Royalty Corporation | 324.56M | 2.66% | 106,607 | 47.11M |
| 273 | IMRX | Immuneering Corporation | 322.85M | 0.20% | 773,728 | - |
| 274 | NGNE | Neurogene Inc. | 321.26M | -11.71% | 542,679 | 925.00K |
| 275 | TARA | Protara Therapeutics, Inc. | 319.92M | -6.13% | 1,149,939 | - |
| 276 | CABA | Cabaletta Bio, Inc. | 317.68M | -0.60% | 2,128,189 | - |
| 277 | CCCC | C4 Therapeutics, Inc. | 307.22M | 17.41% | 6,688,215 | 35.95M |
| 278 | ANL | Adlai Nortye Ltd. | 304.06M | 4.83% | 248,920 | -1.35M |
| 279 | IRD | Opus Genetics, Inc. | 298.62M | 4.09% | 1,267,409 | 14.63M |
| 280 | NERV | Minerva Neurosciences, Inc. | 298.59M | 4.55% | 206,258 | - |
| 281 | XFOR | X4 Pharmaceuticals, Inc. | 297.28M | -1.16% | 255,822 | 33.98M |
| 282 | NAUT | Nautilus Biotechnology, Inc. | 293.03M | -4.13% | 213,067 | - |
| 283 | CLLS | Cellectis S.A. | 287.21M | -2.06% | 79,667 | 82.55M |
| 284 | ACIU | AC Immune SA | 284.46M | -1.88% | 333,934 | 5.48M |
| 285 | SLN | Silence Therapeutics plc | 281.99M | 9.74% | 404,697 | 25.83M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 281.42M | 1.66% | 642,607 | - |
| 287 | FENC | Fennec Pharmaceuticals Inc. | 280.74M | -3.18% | 172,358 | 38.79M |
| 288 | ENLV | Enlivex Ltd. | 275.36M | 0.87% | 341,198 | - |
| 289 | ABEO | Abeona Therapeutics Inc. | 274.21M | -1.17% | 496,149 | 400.00K |
| 290 | PALI | Palisade Bio, Inc. | 268.95M | 1.98% | 2,528,484 | - |
| 291 | IKT | Inhibikase Therapeutics, Inc. | 263.99M | -5.85% | 1,193,293 | 1.00 |
| 292 | STTK | Shattuck Labs, Inc. | 254.38M | 2.55% | 267,927 | 1.00M |
| 293 | OABI | OmniAb, Inc. | 253.36M | 2.33% | 208,742 | 21.09M |
| 294 | CBUS | Cibus, Inc. | 250.63M | 0.54% | 372,400 | 3.79M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 248.91M | -2.54% | 17,556 | 18.97M |
| 296 | OBIO | Orchestra BioMed Holdings, Inc. | 248.44M | 0.46% | 111,195 | 2.82M |
| 297 | CHRS | Coherus Oncology, Inc. | 246.63M | -1.20% | 1,052,228 | 277.73M |
| 298 | SRZN | Surrozen, Inc. | 246.13M | 3.29% | 51,044 | 3.60M |
| 299 | ACHV | Achieve Life Sciences, Inc. | 245.94M | 1.32% | 408,228 | - |
| 300 | ALEC | Alector, Inc. | 243.90M | -9.05% | 1,992,179 | 21.05M |
| 301 | PLX | Protalix BioTherapeutics, Inc. | 243.68M | 5.21% | 1,830,960 | 61.84M |
| 302 | ELTX | Elicio Therapeutics, Inc. | 241.85M | 6.54% | 257,045 | - |
| 303 | NVCT | Nuvectis Pharma, Inc. | 240.28M | 2.37% | 45,619 | - |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 237.26M | 1.46% | 443,722 | 97.60M |
| 305 | VYGR | Voyager Therapeutics, Inc. | 230.74M | 1.22% | 472,037 | 31.32M |
| 306 | CAMP | Camp4 Therapeutics Corporation | 229.06M | -1.67% | 29,807 | 3.80M |
| 307 | HRTX | Heron Therapeutics, Inc. | 226.24M | 0.84% | 1,892,468 | 154.90M |
| 308 | MDWD | MediWound Ltd. | 223.50M | 0.81% | 111,132 | 20.93M |
| 309 | PRLD | Prelude Therapeutics Incorporated | 223.30M | -1.81% | 103,466 | 10.50M |
| 310 | CBIO | Crescent Biopharma, Inc. | 218.96M | -7.36% | 78,537 | 10.84M |
| 311 | HUMA | Humacyte, Inc. | 216.16M | 0.45% | 2,213,318 | 1.57M |
| 312 | OVID | Ovid Therapeutics Inc. | 216.11M | 1.84% | 703,580 | 6.61M |
| 313 | ELDN | Eledon Pharmaceuticals, Inc. | 211.08M | 1.53% | 1,171,796 | - |
| 314 | CGEN | Compugen Ltd. | 210.45M | 24.31% | 2,073,546 | 72.76M |
| 315 | CNTX | Context Therapeutics Inc. | 210.40M | 1.78% | 376,377 | - |
| 316 | EDIT | Editas Medicine, Inc. | 209.88M | -2.27% | 1,042,348 | 46.38M |
| 317 | PMN | ProMIS Neurosciences, Inc. | 204.37M | -3.06% | 124,559 | - |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 203.18M | 1.38% | 712,964 | - |
| 319 | ABOS | Acumen Pharmaceuticals, Inc. | 199.89M | 5.10% | 541,875 | - |
| 320 | GALT | Galectin Therapeutics Inc. | 197.93M | 3.02% | 372,540 | - |
| 321 | RNAC | Cartesian Therapeutics, Inc. | 197.63M | 0.13% | 91,832 | 1.09M |
| 322 | KLRS | Kalaris Therapeutics, Inc. | 194.88M | -0.38% | 27,170 | - |
| 323 | SABS | SAB Biotherapeutics, Inc. | 193.76M | -0.73% | 308,488 | 114.70K |
| 324 | NTHI | NeOnc Technologies Holdings, Inc. | 193.28M | -2.89% | 28,032 | 59.99K |
| 325 | NKTX | Nkarta, Inc. | 191.78M | - | 774,635 | - |
| 326 | TLSA | Tiziana Life Sciences Ltd | 191.44M | 3.45% | 128,382 | - |
| 327 | MOLN | Molecular Partners AG | 188.82M | 2.04% | 690 | 856.30K |
| 328 | VXRT | Vaxart, Inc. | 186.25M | -2.43% | - | 148.20M |
| 329 | SGMT | Sagimet Biosciences Inc. | 186.02M | 0.18% | 263,559 | - |
| 330 | TNXP | Tonix Pharmaceuticals Holding Corp. | 178.86M | 0.07% | 306,014 | 10.30M |
| 331 | KPTI | Karyopharm Therapeutics Inc. | 175.92M | 1.91% | 498,502 | 146.07M |
| 332 | MIST | Milestone Pharmaceuticals Inc. | 175.74M | 1.17% | 947,104 | - |
| 333 | FATE | Fate Therapeutics, Inc. | 174.40M | 1.35% | 1,176,938 | 6.65M |
| 334 | CRBU | Caribou Biosciences, Inc. | 171.98M | -3.16% | 1,093,875 | 9.30M |
| 335 | MENS | Jyong Biotech Ltd. | 169.18M | 2.80% | 287,948 | - |
| 336 | PRQR | ProQR Therapeutics N.V. | 166.45M | -0.63% | 226,726 | 18.86M |
| 337 | RANI | Rani Therapeutics Holdings, Inc. | 165.27M | -0.73% | 802,438 | 1.20M |
| 338 | IPHA | Innate Pharma S.A. | 162.13M | -0.87% | 3,942 | 14.84M |
| 339 | ZNTL | Zentalis Pharmaceuticals, Inc. | 161.88M | 4.60% | 361,531 | 26.87M |
| 340 | SGMO | Sangamo Therapeutics, Inc. | 159.79M | -0.56% | 3,480,586 | 32.88M |
| 341 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 154.71M | -2.57% | 178,621 | - |
| 342 | WHWK | Whitehawk Therapeutics, Inc. | 152.70M | -7.69% | 324,843 | 14.38M |
| 343 | UNCY | Unicycive Therapeutics, Inc. | 150.22M | 0.87% | 527,617 | - |
| 344 | ARTV | Artiva Biotherapeutics, Inc. | 141.62M | -0.86% | 254,748 | 251.00K |
| 345 | CNTB | Connect Biopharma Holdings Limited | 139.76M | 1.21% | 121,028 | 762.00K |
| 346 | ADAG | Adagene Inc. | 139.51M | - | 83,589 | 103.20K |
| 347 | BDTX | Black Diamond Therapeutics, Inc. | 138.45M | -1.62% | 510,426 | 70.00M |
| 348 | IMUX | Immunic, Inc. | 138.29M | 3.92% | 7,211,360 | - |
| 349 | PLYX | Polaryx Therapeutics, Inc. | 136.35M | -5.57% | 148,701 | - |
| 350 | ORMP | Oramed Pharmaceuticals Inc. | 132.94M | -2.20% | 311,000 | 2.00M |
| 351 | CRDF | Cardiff Oncology, Inc. | 132.63M | - | 795,163 | 593.00K |
| 352 | GNLX | Genelux Corporation | 129.31M | -2.01% | 291,039 | 8.00K |
| 353 | ACOG | Alpha Cognition Inc. | 126.10M | -3.33% | 64,980 | 7.43M |
| 354 | TNYA | Tenaya Therapeutics, Inc. | 123.41M | 1.46% | 2,623,176 | - |
| 355 | SPRO | Spero Therapeutics, Inc. | 123.38M | 0.92% | 195,503 | 40.55M |
| 356 | MGNX | MacroGenics, Inc. | 122.72M | -2.51% | 507,288 | 127.63M |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 119.54M | -3.87% | 573,338 | 182.34K |
| 358 | AARD | Aardvark Therapeutics, Inc. | 119.10M | -56.20% | 2,837,351 | - |
| 359 | EQ | Equillium, Inc. | 117.83M | 6.32% | 269,837 | 4.39M |
| 360 | COYA | Coya Therapeutics, Inc. | 115.13M | -1.01% | 146,375 | 3.99M |
| 361 | AGEN | Agenus Inc. | 113.59M | 0.30% | 290,397 | 106.83M |
| 362 | SAVA | Cassava Sciences, Inc. | 112.07M | 1.75% | 603,884 | - |
| 363 | ONCY | Oncolytics Biotech Inc. | 109.76M | -9.73% | 1,639,242 | - |
| 364 | KRRO | Korro Bio, Inc. | 108.58M | -4.95% | 86,134 | 7.37M |
| 365 | TTRX | Turn Therapeutics Inc. | 107.77M | 1.67% | 26,041 | - |
| 366 | GANX | Gain Therapeutics, Inc. | 104.23M | 3.83% | 564,086 | - |
| 367 | DTIL | Precision BioSciences, Inc. | 104.23M | 3.10% | 153,163 | 698.00K |
| 368 | FBIO | Fortress Biotech, Inc. | 102.43M | -3.51% | 393,689 | 62.30M |
| 369 | GOSS | Gossamer Bio, Inc. | 99.20M | 0.87% | 13,749,369 | 44.05M |
| 370 | ANIX | Anixa Biosciences, Inc. | 98.80M | -0.67% | 117,913 | - |
| 371 | VANI | Vivani Medical, Inc. | 97.42M | -0.81% | 150,426 | - |
| 372 | SEER | Seer, Inc. | 97.26M | 0.58% | 484,016 | 16.58M |
| 373 | ATYR | aTyr Pharma, Inc. | 97.01M | 3.15% | 1,274,610 | 190.00K |
| 374 | BMEA | Biomea Fusion, Inc. | 96.86M | - | 877,448 | - |
| 375 | KZIA | Kazia Therapeutics Limited | 96.21M | 4.50% | 211,873 | 1.20M |
| 376 | PMVP | PMV Pharmaceuticals, Inc. | 95.78M | 5.88% | 3,856,014 | - |
| 377 | DWTX | Dogwood Therapeutics, Inc. | 95.59M | 0.74% | 13,589 | - |
| 378 | CGTX | Cognition Therapeutics, Inc. | 93.57M | -2.75% | 803,545 | - |
| 379 | IBIO | iBio, Inc. | 92.92M | -4.61% | 1,008,273 | 300.00K |
| 380 | HURA | TuHURA Biosciences, Inc. | 92.30M | -8.98% | 604,728 | - |
| 381 | CDXS | Codexis, Inc. | 92.13M | 0.99% | 2,559,285 | 52.93M |
| 382 | PYXS | Pyxis Oncology, Inc. | 91.53M | - | 449,651 | 2.82M |
| 383 | OKYO | OKYO Pharma Limited | 90.93M | 3.51% | 296,996 | - |
| 384 | ACTU | Actuate Therapeutics, Inc. | 87.16M | 0.27% | 39,202 | - |
| 385 | VRCA | Verrica Pharmaceuticals Inc. | 85.87M | -1.83% | 132,297 | 30.83M |
| 386 | CSBR | Champions Oncology, Inc. | 84.29M | 1.93% | 10,696 | 58.42M |
| 387 | PYPD | PolyPid Ltd. | 82.82M | 2.12% | 39,437 | - |
| 388 | MCRB | Seres Therapeutics, Inc. | 81.06M | 2.52% | 29,883 | 351.00K |
| 389 | MAIA | MAIA Biotechnology, Inc. | 79.21M | -8.41% | 551,921 | - |
| 390 | PTHS | Pelthos Therapeutics Inc. | 78.17M | -8.35% | 3,028 | 7.41M |
| 391 | PLRX | Pliant Therapeutics, Inc. | 78.04M | -2.31% | 488,433 | - |
| 392 | GUTS | Fractyl Health, Inc. | 76.98M | 6.95% | 2,858,940 | 3.00K |
| 393 | ACET | Adicet Bio, Inc. | 73.67M | 0.55% | 33,197 | - |
| 394 | ANVS | Annovis Bio, Inc. | 70.76M | -0.37% | 434,576 | - |
| 395 | XBIT | XBiotech Inc. | 70.73M | 2.65% | 41,268 | - |
| 396 | MNOV | MediciNova, Inc. | 69.40M | -2.76% | 165,925 | 409.66K |
| 397 | QTTB | Q32 Bio Inc. | 69.16M | 8.55% | 293,251 | - |
| 398 | CING | Cingulate Inc. | 68.14M | 4.31% | 271,807 | - |
| 399 | EXOZ | eXoZymes, Inc. | 67.96M | -8.59% | 4,024 | -700.00 |
| 400 | IMA | ImageneBio, Inc. | 67.85M | -5.21% | 5,239 | 800.00K |
| 401 | NRXS | NeurAxis, Inc. | 67.11M | 5.00% | 146,103 | 3.36M |
| 402 | COEP | Coeptis Therapeutics Holdings, Inc. | 65.89M | -3.61% | 23,689 | 501.00K |
| 403 | MREO | Mereo BioPharma Group plc | 63.25M | 7.26% | 3,292,315 | 500.00K |
| 404 | GRCE | Grace Therapeutics, Inc. | 62.98M | -5.13% | 398,018 | - |
| 405 | ENTX | Entera Bio Ltd. | 62.82M | -1.44% | 105,732 | 124.00K |
| 406 | IFRX | InflaRx N.V. | 62.33M | 0.01% | 157,432 | 73.73K |
| 407 | ATHE | Alterity Therapeutics Limited | 61.98M | -0.32% | 13,255 | 4.96M |
| 408 | TCRX | TScan Therapeutics, Inc. | 59.59M | -0.94% | 437,794 | 8.42M |
| 409 | ICCC | ImmuCell Corporation | 59.16M | -0.46% | 2,806 | 27.77M |
| 410 | TIL | Instil Bio, Inc. | 58.19M | -3.60% | 37,039 | - |
| 411 | SPRB | Spruce Biosciences, Inc. | 58.09M | -1.22% | 23,515 | 697.00K |
| 412 | RLYB | Rallybio Corporation | 57.93M | 45.49% | 3,633,707 | 674.00K |
| 413 | NRXP | NRx Pharmaceuticals, Inc. | 57.53M | -2.96% | 356,449 | 242.00K |
| 414 | MGX | Metagenomi Therapeutics, Inc. | 57.45M | 0.66% | 218,258 | 30.91M |
| 415 | BYSI | BeyondSpring Inc. | 56.34M | 1.48% | 17,326 | 1.88M |
| 416 | LONA | LeonaBio, Inc. | 54.90M | 4.44% | 17,491 | - |
| 417 | HYFT | MindWalk Holdings Corp. | 53.23M | 0.88% | 383,755 | 19.02M |
| 418 | RADX | Radiopharm Theranostics Limited | 53.02M | -0.80% | 47,504 | 10.86M |
| 419 | PSTV | Plus Therapeutics, Inc. | 53.00M | -1.02% | 3,601,790 | 5.26M |
| 420 | NTRB | Nutriband Inc. | 52.39M | -2.93% | 8,782 | 2.28M |
| 421 | KZR | Kezar Life Sciences, Inc. | 51.63M | 5.22% | 109,428 | - |
| 422 | INKT | MiNK Therapeutics, Inc. | 51.40M | - | 4,136 | - |
| 423 | OSTX | OS Therapies Incorporated | 50.36M | -2.72% | 345,635 | - |
| 424 | TVGN | Tevogen Bio Holdings Inc. | 50.14M | -5.83% | 319,158 | - |
| 425 | LPCN | Lipocine Inc. | 49.08M | -11.24% | 188,297 | 4.32M |
| 426 | ACRV | Acrivon Therapeutics, Inc. | 48.28M | 1.32% | 1,092,964 | - |
| 427 | ESLA | Estrella Immunopharma, Inc. | 47.92M | -6.56% | 61,273 | - |
| 428 | KLTO | Klotho Neurosciences, Inc. | 47.48M | 21.46% | 3,505,099 | - |
| 429 | NXTC | NextCure, Inc. | 43.89M | -1.57% | 21,067 | - |
| 430 | APLM | Apollomics, Inc. | 43.29M | -0.20% | 4,468 | 6.93M |
| 431 | ALGS | Aligos Therapeutics, Inc. | 42.86M | -0.92% | 94,392 | 2.65M |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 42.63M | -2.36% | 97,315 | - |
| 433 | VERU | Veru Inc. | 42.05M | 1.55% | 36,517 | 16.89M |
| 434 | IBO | Impact BioMedical Inc. | 41.93M | -7.93% | 32,298 | 25.00K |
| 435 | LITS | Lite Strategy, Inc. | 40.36M | -1.77% | 207,022 | - |
| 436 | XLO | Xilio Therapeutics, Inc. | 39.73M | 2.37% | 532,590 | 31.80M |
| 437 | ATOS | Atossa Therapeutics, Inc. | 38.75M | 1.58% | 88,069 | - |
| 438 | LSTA | Lisata Therapeutics, Inc. | 38.63M | 6.83% | 79,002 | 1.07M |
| 439 | OKUR | OnKure Therapeutics, Inc. | 38.34M | 4.43% | 81,894 | - |
| 440 | PDSB | PDS Biotechnology Corporation | 37.87M | 2.52% | 202,779 | - |
| 441 | JSPR | Jasper Therapeutics, Inc. | 37.78M | -2.17% | 101,869 | - |
| 442 | SNSE | Sensei Biotherapeutics, Inc. | 37.72M | -2.26% | 121,179 | - |
| 443 | NBY | NovaBay Pharmaceuticals, Inc. | 37.36M | -0.69% | 453,888 | 10.30M |
| 444 | TVRD | Tvardi Therapeutics, Inc. | 37.15M | -0.75% | 52,088 | - |
| 445 | ABVC | ABVC BioPharma, Inc. | 36.55M | 12.98% | 187,116 | 797.92K |
| 446 | CRVO | CervoMed Inc. | 35.99M | -2.51% | 101,325 | 6.16M |
| 447 | PLUR | Pluri Inc. | 35.78M | -1.11% | 3,069 | 1.34M |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 35.56M | -3.39% | 112,443 | 90.00K |
| 449 | PTN | Palatin Technologies, Inc. | 35.46M | 7.42% | 15,625 | 8.96M |
| 450 | ATRA | Atara Biotherapeutics, Inc. | 35.40M | -9.41% | 128,189 | 151.93M |
| 451 | INMB | INmune Bio Inc. | 35.36M | 3.10% | 351,532 | 50.00K |
| 452 | CELU | Celularity Inc. | 35.08M | -1.10% | 12,166 | 40.58M |
| 453 | OTLK | Outlook Therapeutics, Inc. | 35.05M | 0.31% | 452,463 | 205.70K |
| 454 | RNXT | RenovoRx, Inc. | 32.32M | -0.14% | 234,591 | 928.00K |
| 455 | RNTX | Rein Therapeutics Inc. | 31.54M | 5.26% | 105,792 | - |
| 456 | CVM | CEL-SCI Corporation | 31.00M | -10.09% | 95,261 | - |
| 457 | LTRN | Lantern Pharma Inc. | 30.59M | -3.01% | 35,332 | - |
| 458 | TPST | Tempest Therapeutics, Inc. | 29.93M | -2.63% | 26,564 | - |
| 459 | ANTX | AN2 Therapeutics, Inc. | 29.59M | -1.82% | 31,204 | - |
| 460 | KYNB | Kyntra Bio, Inc. | 29.13M | 3.90% | 35,395 | 8.30M |
| 461 | NRSN | NeuroSense Therapeutics Ltd. | 28.39M | -6.48% | 103,747 | - |
| 462 | FBLG | FibroBiologics, Inc. | 28.36M | 27.66% | 3,621,909 | - |
| 463 | HOWL | Werewolf Therapeutics, Inc. | 28.30M | -2.87% | 588,565 | 1.14M |
| 464 | PASG | Passage Bio, Inc. | 27.88M | -3.83% | 17,809 | - |
| 465 | DYAI | Dyadic International, Inc. | 27.72M | -1.68% | 103,154 | 3.34M |
| 466 | BCTX | BriaCell Therapeutics Corp. | 27.70M | 5.24% | 310,890 | - |
| 467 | HYPD | Hyperion DeFi, Inc. | 27.29M | 15.25% | 494,442 | 345.32K |
| 468 | EVAX | Evaxion A/S | 26.94M | 2.22% | 15,876 | 7.65M |
| 469 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 26.88M | 7.13% | 2,751,716 | - |
| 470 | AEON | AEON Biopharma, Inc. | 26.82M | -5.36% | 36,603 | - |
| 471 | IGC | IGC Pharma, Inc. | 26.17M | -1.51% | 235,062 | 1.11M |
| 472 | BOLD | Boundless Bio, Inc. | 25.97M | - | 41,257 | - |
| 473 | CUE | Cue Biopharma, Inc. | 25.76M | 0.79% | 180,258 | 7.10M |
| 474 | LIXT | Lixte Biotechnology Holdings, Inc. | 25.53M | 1.38% | 16,837 | - |
| 475 | BRNS | Barinthus Biotherapeutics plc | 24.98M | 4.74% | 18,194 | 14.97M |
| 476 | SNTI | Senti Biosciences, Inc. | 24.47M | -1.38% | 89,453 | - |
| 477 | SKYE | Skye Bioscience, Inc. | 24.40M | 2.17% | 165,435 | - |
| 478 | IOBT | IO Biotech, Inc. | 23.70M | -5.62% | 837,310 | - |
| 479 | VTGN | Vistagen Therapeutics, Inc. | 23.63M | 1.76% | 497,420 | 789.00K |
| 480 | MRKR | Marker Therapeutics, Inc. | 23.34M | -5.41% | 101,696 | 4.69M |
| 481 | XCUR | Exicure, Inc. | 23.07M | -3.21% | 7,657 | 500.00K |
| 482 | DARE | Daré Bioscience, Inc. | 23.01M | -5.29% | 120,123 | -57.13K |
| 483 | NEUP | Neuphoria Therapeutics Inc. | 22.97M | 2.65% | 80,158 | 14.99M |
| 484 | GNTA | Genenta Science S.p.A. | 22.96M | -1.08% | 20,578 | - |
| 485 | NNVC | NanoViricides, Inc. | 20.95M | -7.62% | 200,561 | - |
| 486 | VYNE | VYNE Therapeutics Inc. | 20.10M | 0.60% | 646,638 | 570.00K |
| 487 | CVKD | Cadrenal Therapeutics, Inc. | 20.08M | 1.18% | 130,496 | - |
| 488 | PLRZ | Polyrizon Ltd. | 19.93M | 0.10% | 20,978 | - |
| 489 | INTS | Intensity Therapeutics, Inc. | 19.21M | -1.04% | 28,829 | - |
| 490 | SER | Serina Therapeutics, Inc. | 19.09M | -1.67% | 55,347 | 116.00K |
| 491 | EDSA | Edesa Biotech, Inc. | 19.03M | 3.64% | 4,953,603 | - |
| 492 | KTTA | Pasithea Therapeutics Corp. | 18.80M | -7.67% | 79,520 | - |
| 493 | LEXX | Lexaria Bioscience Corp. | 17.67M | 1.57% | 488,700 | 522.00K |
| 494 | JUNS | Jupiter Neurosciences, Inc. | 17.45M | -4.38% | 45,424 | - |
| 495 | INAB | IN8bio, Inc. | 16.60M | - | 35,469 | - |
| 496 | CTXR | Citius Pharmaceuticals, Inc. | 16.18M | -2.30% | 115,952 | 3.94M |
| 497 | ALLR | Allarity Therapeutics, Inc. | 16.00M | 2.58% | 55,266 | - |
| 498 | HOTH | Hoth Therapeutics, Inc. | 15.82M | 0.99% | 122,278 | - |
| 499 | BCAB | BioAtla, Inc. | 15.15M | -17.54% | 3,700,928 | 11.00M |
| 500 | CRIS | Curis, Inc. | 14.93M | -4.39% | 122,678 | 11.65M |
| 501 | ITRM | Iterum Therapeutics plc | 14.92M | 6.77% | 727,089 | 390.00K |
| 502 | BCDA | BioCardia, Inc. | 14.54M | 6.20% | 84,782 | 3.00K |
| 503 | COCP | Cocrystal Pharma, Inc. | 14.47M | - | 42,804 | - |
| 504 | QNTM | Quantum BioPharma Ltd. | 13.64M | 1.41% | 43,944 | - |
| 505 | NCEL | NewcelX Ltd. | 13.08M | -1.03% | 2,246 | - |
| 506 | TRAW | Traws Pharma, Inc. | 12.95M | -1.82% | 37,637 | 2.85M |
| 507 | KAPA | Kairos Pharma, Ltd. | 12.70M | 0.74% | 434,435 | - |
| 508 | CLRB | Cellectar Biosciences, Inc. | 12.68M | -7.86% | 38,013 | - |
| 509 | BLRX | BioLineRx Ltd. | 12.49M | 1.06% | 9,965 | 12.74M |
| 510 | GTBP | GT Biopharma, Inc. | 12.45M | -2.30% | 811,021 | - |
| 511 | GDTC | CytoMed Therapeutics Limited | 12.23M | -1.85% | 21,682 | 573.19K |
| 512 | CMMB | Chemomab Therapeutics Ltd. | 12.06M | 5.38% | 84,080 | - |
| 513 | SNGX | Soligenix, Inc. | 11.80M | -0.85% | 96,533 | 2.34K |
| 514 | MBRX | Moleculin Biotech, Inc. | 11.74M | -0.42% | 82,922 | - |
| 515 | LGVN | Longeveron Inc. | 11.63M | 0.66% | 218,987 | 1.44M |
| 516 | IMNN | Imunon, Inc. | 11.19M | 1.23% | 22,296 | - |
| 517 | PHIO | Phio Pharmaceuticals Corp. | 10.98M | -10.53% | 606,184 | - |
| 518 | KALA | KALA BIO, Inc. | 10.96M | 2.11% | 193,861 | - |
| 519 | LIMN | Liminatus Pharma, Inc. | 10.88M | -4.15% | 1,017,075 | - |
| 520 | AKTX | Akari Therapeutics, Plc | 10.67M | -0.25% | 212,680 | - |
| 521 | OSRH | OSR Holdings, Inc. | 10.53M | -0.49% | 245,758 | -90.52K |
| 522 | BIVI | BioVie Inc. | 10.10M | -2.90% | 97,950 | - |
| 523 | ICU | SeaStar Medical Holding Corporation | 9.77M | -1.81% | 89,525 | 881.00K |
| 524 | CDIO | Cardio Diagnostics Holdings, Inc. | 9.50M | -20.61% | 2,229,782 | 15.78K |
| 525 | LNAI | Lunai Bioworks Inc. | 9.43M | 5.26% | 114,831 | - |
| 526 | RNAZ | TransCode Therapeutics, Inc. | 9.28M | 5.31% | 11,194 | - |
| 527 | GRDX | GridAI Technologies Corp. | 9.01M | 16.52% | 154,828 | - |
| 528 | NCNA | NuCana plc | 8.95M | -0.46% | 18,061 | - |
| 529 | BOLT | Bolt Biotherapeutics, Inc. | 8.70M | 0.22% | 30,096 | 5.20M |
| 530 | CLGN | CollPlant Biotechnologies Ltd. | 7.85M | -3.54% | 80,781 | 2.48M |
| 531 | ALZN | Alzamend Neuro, Inc. | 7.65M | - | 37,625 | - |
| 532 | ERNA | Ernexa Therapeutics Inc. | 7.59M | -1.68% | 455,720 | 1,000.00 |
| 533 | PMCB | PharmaCyte Biotech, Inc. | 7.57M | 2.13% | 58,428 | - |
| 534 | KPRX | Kiora Pharmaceuticals, Inc. | 7.56M | -1.44% | 11,319 | 20.00K |
| 535 | MLEC | Moolec Science SA | 7.46M | -22.78% | 72,546 | 7.83M |
| 536 | TCRT | Alaunos Therapeutics, Inc. | 7.41M | 4.08% | 40,272 | 6.00K |
| 537 | EVGN | Evogene Ltd. | 7.33M | -1.57% | 24,788 | 8.02M |
| 538 | CALC | CalciMedica, Inc. | 7.31M | -1.80% | 442,417 | - |
| 539 | ASBP | Aspire Biopharma Holdings, Inc. | 7.29M | 4.32% | 145,972 | 1.94K |
| 540 | ADXN | Addex Therapeutics Ltd | 7.28M | - | 718 | 198.82K |
| 541 | QNRX | Quoin Pharmaceuticals, Ltd. | 7.15M | 1.79% | 24,928 | - |
| 542 | TOVX | Theriva Biologics, Inc. | 7.09M | -0.65% | 2,421,823 | - |
| 543 | APVO | Aptevo Therapeutics Inc. | 7.07M | -3.14% | 4,647 | - |
| 544 | MBIO | Mustang Bio, Inc. | 6.99M | -5.21% | 57,120 | - |
| 545 | PULM | Pulmatrix, Inc. | 6.90M | -36.79% | 397,690 | 3.00K |
| 546 | APM | Aptorum Group Limited | 6.88M | 8.28% | 42,149 | - |
| 547 | PHGE | BiomX Inc. | 6.81M | -2.29% | 21,135 | - |
| 548 | XTLB | XTL Biopharmaceuticals Ltd. | 6.64M | 0.25% | 26,643 | 968.00K |
| 549 | IMRN | Immuron Limited | 6.46M | -3.90% | 11,078 | 4.99M |
| 550 | CELZ | Creative Medical Technology Holdings, Inc. | 6.33M | - | 21,398 | 6.00K |
| 551 | CANF | Can-Fite BioPharma Ltd. | 6.24M | 2.32% | 20,519 | 560.00K |
| 552 | APRE | Aprea Therapeutics, Inc. | 6.19M | -3.45% | 120,613 | 488.24K |
| 553 | REVB | Revelation Biosciences, Inc. | 6.12M | -2.27% | 103,597 | - |
| 554 | PPBT | Purple Biotech Ltd | 6.02M | - | 53,249 | - |
| 555 | XBIO | Xenetic Biosciences, Inc. | 5.84M | 0.79% | 7,345 | 2.86M |
| 556 | VIVS | VivoSim Labs, Inc. | 5.74M | 1.38% | 148,917 | 142.00K |
| 557 | CLDI | Calidi Biotherapeutics, Inc. | 5.72M | -1.59% | 31,830 | - |
| 558 | QNCX | Quince Therapeutics, Inc. | 5.50M | -21.40% | 22,971,364 | - |
| 559 | SLXN | Silexion Therapeutics Corp | 5.41M | 0.29% | 13,584 | - |
| 560 | PCSA | Processa Pharmaceuticals, Inc. | 5.17M | 5.07% | 33,587 | - |
| 561 | BGMS | Bio Green Med Solution, Inc. | 5.00M | 4.08% | 14,698 | 81.00K |
| 562 | CYCN | Cyclerion Therapeutics, Inc. | 4.95M | -3.70% | 80,456 | 2.86M |
| 563 | MTVA | MetaVia Inc. | 4.91M | 1.32% | 126,034 | - |
| 564 | SILO | Silo Pharma, Inc. | 4.75M | -2.70% | 475,222 | 72.10K |
| 565 | INDP | Indaptus Therapeutics, Inc. | 4.71M | 1.79% | 10,198 | - |
| 566 | GNPX | Genprex, Inc. | 4.61M | -0.50% | 365,207 | - |
| 567 | BRTX | BioRestorative Therapies, Inc. | 4.58M | -6.39% | 2,287,884 | 383.40K |
| 568 | DCOY | Decoy Therapeutics Inc. | 4.30M | -1.01% | 38,375 | - |
| 569 | GOVX | GeoVax Labs, Inc. | 4.10M | -2.50% | 27,554 | 3.35M |
| 570 | GLMD | Galmed Pharmaceuticals Ltd. | 4.06M | 0.98% | 15,723 | - |
| 571 | MTNB | Matinas BioPharma Holdings, Inc. | 3.96M | 1.73% | 9,785 | - |
| 572 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.91M | -2.25% | 29,977 | 1.36M |
| 573 | ACXP | Acurx Pharmaceuticals, Inc. | 3.90M | 2.00% | 33,869 | - |
| 574 | ELAB | PMGC Holdings Inc. | 3.70M | -4.20% | 142,355 | 285.95K |
| 575 | GRI | GRI Bio, Inc. | 3.67M | -0.39% | 24,834 | - |
| 576 | JAGX | Jaguar Health, Inc. | 3.63M | -0.77% | 713,384 | 11.79M |
| 577 | OGEN | Oragenics, Inc. | 3.55M | -0.99% | 58,379 | - |
| 578 | HCWB | HCW Biologics Inc. | 3.17M | 1.74% | 58,082 | 422.03K |
| 579 | ENVB | Enveric Biosciences, Inc. | 3.13M | -4.26% | 89,885 | - |
| 580 | SCNI | Scinai Immunotherapeutics Ltd. | 2.95M | -4.23% | 33,258 | 1.15M |
| 581 | PBM | Psyence Biomedical Ltd. | 2.94M | 0.79% | 21,790 | - |
| 582 | XRTX | XORTX Therapeutics Inc. | 2.91M | 2.44% | 22,061 | - |
| 583 | PPCB | Propanc Biopharma, Inc. | 2.89M | -5.65% | 204,300 | - |
| 584 | ADIL | Adial Pharmaceuticals, Inc. | 2.76M | -1.98% | 51,091 | - |
| 585 | DRMA | Dermata Therapeutics, Inc. | 2.74M | -4.17% | 183,697 | - |
| 586 | SPRC | SciSparc Ltd. | 2.57M | -8.85% | 287,710 | 1.31M |
| 587 | ARTL | Artelo Biosciences, Inc. | 2.42M | -4.20% | 17,585 | - |
| 588 | CMND | Clearmind Medicine Inc. | 2.19M | 7.96% | 62,176 | - |
| 589 | ENSC | Ensysce Biosciences, Inc. | 2.18M | -3.72% | 6,740,159 | 4.49M |
| 590 | BBLG | Bone Biologics Corporation | 2.14M | 3.30% | 18,526 | - |
| 591 | LYRA | Lyra Therapeutics, Inc. | 2.11M | 17.82% | 688,685 | 600.00K |
| 592 | CNSP | CNS Pharmaceuticals, Inc. | 1.94M | 0.64% | 7,105 | - |
| 593 | CDT | CDT Equity Inc. | 1.90M | -5.70% | 105,692 | - |
| 594 | AZTR | Azitra, Inc. | 1.77M | -6.06% | 727,274 | 7.50K |
| 595 | VRAX | Virax Biolabs Group Limited | 1.66M | -1.98% | 209,643 | 2.99K |
| 596 | ONCO | Onconetix, Inc. | 1.01M | -3.06% | 57,513 | 1.22M |
| 597 | ADTX | Aditxt, Inc. | 853.38K | 5.10% | 107,771 | 5.95K |
| 598 | BDRX | Biodexa Pharmaceuticals Plc | 847.18K | -6.48% | 78,365 | 104.90K |